Asset Manager

Updated:

MNX Global Logistics Corp.

MNX Global Logistics was a precision logistics firm headquartered in Long Beach, California, focused on pharmaceutical and biotech supply chains.

MNX Global Logistics Corp.

MNX Global Logistics was a precision logistics firm headquartered in Long Beach, California, focused on pharmaceutical and biotech supply chains. It provided temperature-controlled transport for clinical trial materials, radiopharmaceuticals, and biological specimens across more than 220 countries and territories. The company claimed expertise in cell and gene therapy logistics, including cryogenic shipments and GMP storage. The company's service lines included complex secure logistics, patient-driven services, lab advantages, and packaging as a service. It supported the full pharmaceutical development lifecycle, from manufacturing to clinical trial sites and direct-to-patient delivery. MNX maintained a global network of depots, laboratories, and handling facilities for temperature-sensitive materials across all ranges. In 2024, MNX officially joined Marken under the single global brand Marken, UPS Healthcare Precision Logistics (per firm website, 2026). The combined organization employs roughly 4,000 experts and handles over 6.6 million shipments each year. Polar Speed, another UPS Healthcare unit, was also folded into Marken to strengthen in-network pharmacy and patient services. The structural differentiator was MNX's specialization in high-stakes, regulated logistics for radiopharmaceuticals and advanced therapies—a niche requiring validated processes, regulatory oversight, and controlled environments. Its integration into UPS Healthcare gave it access to broader infrastructure while maintaining specialized cold-chain and secure logistics capabilities.

Website
mnx.com

General information

Firm type

Asset Manager

Year founded

AUM

Undisclosed

Location

Region

North America

Country

United States

City

Long Beach

Corporate office

Long Beach, United States

Sector focus

LogisticsSupply Chain TechLife Sciences LogisticsClinical Trial LogisticsRadiopharma LogisticsCold Chain Logistics

Frequently asked questions

Who operates investment decisions at MNX Global Logistics?

MNX was a logistics operating company, not an investment firm, and no named investment decision-makers were publicly disclosed. Its parent, UPS Healthcare, oversaw strategy after the acquisition and rebrand.

Is MNX structured as a single-family office or a logistics company?

MNX was a precision logistics company serving pharmaceutical and biotech clients. It is not a family office or asset manager.

Does MNX participate in fund commitments or only direct deals?

No, MNX was a service provider in supply chain logistics, not an investor committing capital to funds or deals.

What investment stages does MNX target?

MNX did not target investment stages. It provided logistics services across the pharmaceutical value chain, from manufacturing to clinical trial delivery.

How is MNX related to its parent company?

MNX was acquired by UPS and subsequently folded into Marken, UPS Healthcare Precision Logistics. The brand is being retired, but the operational expertise remains within the broader UPS Healthcare logistics network.

Where does the underlying wealth come from?

Not applicable. MNX was a commercial logistics company, not a wealth management or family office entity.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on family offices?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo